Despite efforts for improvement, the "State of the Air" report reveals concerns.

Published Date: 23 Apr 2023

Despite Improvement Efforts, the "State of the Air" Report Highlights Issues.

Read Full News

Latest News

Australia Confirms First H5N1 Bird Flu Case in Local Mammal

Australia on Sunday confirmed its first case of H5N1 bird flu in a mammal, with the deadly virus ⁠found in a long-nosed fur seal in South Australia state.

Nerandomilast Lowers Mortality Risk in Pulmonary Fibrosis

Nerandomilast is associated with reduced mortality risk in patients with pulmonary fibrosis, a pooled analysis of two trials shows.

Mastering the HER2 Spectrum for Individualized Management of Advanced/Metastatic NSCLC

Mastering the HER2 Spectrum for Individualized Management of Advanced/Metastatic NSCLC

Expert Insights on the Next Wave of IO Combinations in mNSCLC

Expert Insights on the Next Wave of IO Combinations in mNSCLC

Treating Advanced Disease With Bispecific ADCs: Mechanisms of Action and Therapeutic Rationale for Bispecific ADCs in Solid Tumors

Treating Advanced Disease With Bispecific ADCs: Mechanisms of Action and Therapeutic Rationale for Bispecific ADCs in Solid Tumors

New GLP-1 Concern; FDA Sued by Health Groups; Over 750 Dead in Ebola Outbreak

Health news and commentary gathered by MedPage Today staff

Todays Updates

EU Flags Shortage Of Schizophrenia Drug Injections Due to Manufacturing Issues

(This Aug 27 story has been republished, with no changes to text.)

Black Canadians Face Multiple Barriers to Blood Donation

Barriers to blood donations from Black people in Canada are rooted in racism and restrictive policies.

Can Accelerated Salvage RT Improve Prostate Cancer Control?

After biochemical recurrence, hypofractionated RT may be no more effective than standard RT for disease control — and may have more late side effects.

Laser Therapy Shows Promise for Brain Tumors

Researchers followed 787 patients with brain tumors treated with laser therapy for up to 5 years.

Ibrutinib Fails in High-Risk Early-Stage CLL

Ibrutinib improves event-free survival in certain genetic subgroups of early-stage chronic lymphocytic leukemia but fails to extend overall survival.

Todays Updates

EU Flags Shortage Of Schizophrenia Drug Injections Due to Manufacturing Issues

(This Aug 27 story has been republished, with no changes to text.)

Black Canadians Face Multiple Barriers to Blood Donation

Barriers to blood donations from Black people in Canada are rooted in racism and restrictive policies.

Can Accelerated Salvage RT Improve Prostate Cancer Control?

After biochemical recurrence, hypofractionated RT may be no more effective than standard RT for disease control — and may have more late side effects.

Laser Therapy Shows Promise for Brain Tumors

Researchers followed 787 patients with brain tumors treated with laser therapy for up to 5 years.

Ibrutinib Fails in High-Risk Early-Stage CLL

Ibrutinib improves event-free survival in certain genetic subgroups of early-stage chronic lymphocytic leukemia but fails to extend overall survival.

Latest News

Australia on Sunday confirmed its first case of H5N1 bird flu in a mammal, with the deadly virus ⁠found in a long-nosed fur seal in South Australia state.

Nerandomilast is associated with reduced mortality risk in patients with pulmonary fibrosis, a pooled analysis of two trials shows.

Mastering the HER2 Spectrum for Individualized Management of Advanced/Metastatic NSCLC

Expert Insights on the Next Wave of IO Combinations in mNSCLC

Treating Advanced Disease With Bispecific ADCs: Mechanisms of Action and Therapeutic Rationale for Bispecific ADCs in Solid Tumors

Health news and commentary gathered by MedPage Today staff

News All Time

Real-World Study Backs Mepolizumab in Rhinosinusitis With Nasal Polyps

— 20% of patients were on their way to remission

Tenax Heart Drug Fails to Improve Walking Results in Study, Shares Plunge

Tenax Therapeutics said on Monday its experimental drug did not significantly improve how far patients could walk compared with ⁠placebo in a late-stage trial for a...

Overheard in Medicine: Pandemic Wounds Reopened

Overhead in Medicine is a Medscape digest that surfaces a few of the week’s top posts from major medical subreddits.

Ivacaftor Boosts Height and Lung Function in Cystic Fibrosis

Children and young adults with cystic fibrosis, especially those with severe CFTR variants, who receive ivacaftor have improved height and lung capacity than peers who do not receive ivacaftor.

Housing Aid Linked to Better NSCLC Survival

Housing assistance was associated with lower mortality among older adults with NSCLC, but the survival advantage was not explained by differences in guideline-concordant treatment.

More Bronchiectasis Patients Benefit From HEMT

Data from the US Bronchiectasis and NTM Research Registry show improvements in cough and exacerbations with highly effective modulator therapy.

Integrating Evolving IO Strategies in Frontline mNSCLC Management

Integrating Evolving IO Strategies in Frontline mNSCLC Management

Case Report: Paradoxical Bronchoconstriction with Short-Acting Beta Agonist

Clinicians perform pulmonary function tests to find the cause

Why Is a Fit Swimmer Breathless and Coughing Up Blood?

Case highlights a little-known, potentially dangerous, often recurrent condition of swimmers

Psychosis and Cannabis Legalization: Where's the Evidence?

As marijuana policy shifts nationwide, researchers are tracking possible link to psychosis

FDA Staff Blindsided by Move Allowing More E-Cigs, Nicotine Pouches Onto Market

It's highly unusual for the FDA to draft new policies without input from the staffers

Chronic Sinus Inflammation Linked to Roadway Gases

Gaseous pollutants from traffic sources add to evidence for particulate-matter harms

Targeted Lung Cancer Drug Aces Confirmatory Trial in Frontline Setting

Upfront treatment options set to expand for NSCLC patients with EGFR exon 20 insertions

Drug Combo for Lung Cancer Beats Pembrolizumab in First-Line Trial

Antibody-drug conjugate plus pembrolizumab superior to pembrolizumab alone in PD-L1 expressors

Upfront Ivonescimab Plus Chemo Bests PD-1 Inhibitor Combo in Advanced NSCLC

HARMONi-6 showed 34% drop in death risk, but trial had an all-Asian population, expert warned

'Immediately Practice-Changing' Lung Cancer Trial in Curative Setting

Substantial EFS improvement with selpercatinib in RET fusion-positive disease

Recommended News For You

It has been discovered that personalized dosing in the treatment of prostate cancer improves patient outcomes.

DBT Reduced Suicide Attempts in Adolescents with Bipolar Disorder.

NHS Offers Targeted Radiotherapy for Early Prostate Cancer

Tafasitamab-Based Combination Boosts PFS in Relapsed/Refractory Follicular Lymphoma

Weight loss trial reports success for breast cancer patients at one year mark

Cancer Warnings on Alcohol? Surge in GI Illnesses; Swab Detects Kids' Asthma Type

Even after a partial ban, asbestos is still used and is a deadly carcinogen, according to the EPA.

Recommended Articles For You

Cancer Vaccines in Solid Tumors: Current Landscape, Mechanisms, and Clinical Implications 

Anemia Symptoms: What You Need to Know  

Bispecific Antibodies in DLBCL & Myeloma: Clinical Insights for Physicians 

Tumor Dormancy Dynamics and Recurrence-Free Survival Patterns 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

I Was Told I Had 6 Months to Live. That Was 20 Years Ago.

2.

Glofitamab Regimen Improves Survival in DLBCL

3.

Scientists hail the cervical cancer treatment as the most remarkable breakthrough in 20 years.

4.

Sarah Ferguson was identified as having malignant melanoma. These are the most recent therapies.

5.

Gatekeeping May Reduce Pediatric Cancer Trial Participation

1.

What is Mullerian and How Does it Affect Your Health

2.

Senescence in Cancer Therapy: Mechanisms, Clinical Relevance, and Therapeutic Implications

3.

Unlocking the Mystery of Granulomas: A Closer Look at the Causes and Treatment

4.

Emerging Models in Oncology for Specialists

5.

AI in the War on Cancer: How Digital Tools are Revolutionizing Oncology

1.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

2.

International Cancer Conference

3.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

4.

Asian Symposium on Advancement in Hematology and Oncology

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion & Conclusion

2.

Navigating the Complexities of Ph Negative ALL - Part V

3.

Cost Burden/ Burden of Hospitalization For R/R ALL Patients

4.

Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VIII

5.

Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VI

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot